Financial condition report

Enovix Completes Ordering of Laser Patterning and Assembly Line Equipment for Gen2 Autoline

Retrieved on: 
Wednesday, November 16, 2022
Lithium, Result, Financial condition report, Cybook Gen1, Analysis, Energy Independence and Security Act of 2007, 3D, Security (finance), Autoline Detroit, Mobile phone

FREMONT, Calif., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Enovix Corporation (Enovix) (Nasdaq: ENVX), the leader in the design and manufacture of next generation 3D Silicon Lithium-ion batteries, today announced that it has placed the remaining purchase orders for the laser patterning and assembly line equipment of its Gen2 Autoline.

Key Points: 
  • FREMONT, Calif., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Enovix Corporation (Enovix) (Nasdaq: ENVX), the leader in the design and manufacture of next generation 3D Silicon Lithium-ion batteries, today announced that it has placed the remaining purchase orders for the laser patterning and assembly line equipment of its Gen2 Autoline.
  • The Gen2 Autoline will be the copy exact platform from which the company plans to scale up production to meet the strong demand for its advanced batteries.
  • Ordering the laser patterning and assembly line equipment follows earlier purchase orders for long-lead materials, system design, and proof-of-concept hardware fabrication to demonstrate the design improvements built into Gen2.
  • The full Gen2 packaging line was previously ordered in September 2022.

Global Water Resources to Provide Water Services to New P&G Manufacturing Facility at Inland Port Arizona

Retrieved on: 
Wednesday, November 16, 2022
COVID-19, Growth, Population growth, WEF, Result, Financial condition report, ACC, Arizona Corporation Commission, Fabric softener, Procter & Gamble, Lucid, Organization, TWM, Economic development, TSX, Risk, Farmer, Policy, Future, Analysis, Annual report, Kohler, Public expenditure, Inland port, Miller v. Arizona Corporation Commission, Water Environment Federation, Water cycle, Security (finance), NYSE, PG, Water, Ecube Labs, Vaccine, P&G, Rate, ACA, GWR, Global Water Foundation, Acquisition, Renewable energy, Canal, Recycling, Risk management

The facility will be located on 427 acres at Inland Port Arizona , a 2,700-acre mega-site currently under development by Saint Holdings.

Key Points: 
  • The facility will be located on 427 acres at Inland Port Arizona , a 2,700-acre mega-site currently under development by Saint Holdings.
  • Inland Port Arizona falls within a 3.4 square mile region in the central Arizona corridor between Tucson and Phoenix, an area where Global Water received a certificate of convenience and necessity permit from the Arizona Corporation Commission to exclusively provide water, wastewater and recycled water services.
  • Global Water will now work directly with P&G to provide water, wastewater and recycled water services to the planned manufacturing facility.
  • Global Water Resources, Inc. is a leading water resource management company that owns and operates 16 utilities which provide water, wastewater, and recycled water services.

Arbe named as CES 2023 Innovation Awards Honoree

Retrieved on: 
Wednesday, November 16, 2022
Result, ADAS, Perception, Radar, Financial condition report, Conversation, Engineering, Weather, Safety, TEL, Transport, Government, Analysis, Las Vegas Convention Center, Prospectus, CES, Security (finance), CTA, Robotics, Consumer Technology Association, Risk, Human, Instrumentation

TEL AVIV, Israel, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Arbe Robotics Ltd. (Nasdaq: ARBE) ("Arbe"), a global leader in Perception Radar Chipset Solutions, today announced that it has been named a CES 2023 Innovation Awards Honoree for its 360 Radar-Based Perception.

Key Points: 
  • TEL AVIV, Israel, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Arbe Robotics Ltd. (Nasdaq: ARBE) ("Arbe"), a global leader in Perception Radar Chipset Solutions, today announced that it has been named a CES 2023 Innovation Awards Honoree for its 360 Radar-Based Perception.
  • This years CES Innovation Awards program received a record high number of over 2,100 submissions.
  • The CES Innovation Awards program, owned and produced by the Consumer Technology Association (CTA) , is an annual competition honoring outstanding design and engineering in 28 consumer technology product categories.
  • Statements that are not historical facts, including any statements that are made at the CES Innovation Awards program are forward-looking statements.

DSG Global Inc. Files its Form 10-Q and Announces Financial Results for Q3 2022 Including Revenue Growth of 186% from Q3 2021

Retrieved on: 
Tuesday, November 15, 2022
Software, COVID-19, Result, Financial condition report, Conversation, Golf, History, Wi-Fi, Form 10-Q, Risk, Club Car, Transport, EV, Village, Annual report, Sumathi Best Television Current Reporting Award, VTS, Analysis, Security (finance), Sport utility vehicle, Vantage, News, TAG, TEXT, YE, OTCQB, GPS, Fleet management, Satellite navigation device, Video game, Ridesharing company, Risk management, Online shopping, Infinity

Sales for Q3 2022 totaled $1,425,673 compared to $498,380 for Q3 2021, an increase of $927,293 or 186%.

Key Points: 
  • Sales for Q3 2022 totaled $1,425,673 compared to $498,380 for Q3 2021, an increase of $927,293 or 186%.
  • As of September 30, 2022, the Company had additional signed contracts which it is working to fulfill by YE.
  • Gross profit for Q3 2022 totaled $472,832, compared to $271,928 for Q2 2021, an increase of $200,904 or 74%.
  • Gross profit for Q3 2022 totaled $1,090,122 compared to $822,026 for Q3 2021, an increase of $268,096 or 32.61%.

Super League Gaming Announces Preliminary Third Quarter 2022 Financial Results

Retrieved on: 
Tuesday, November 15, 2022
Marketing, Result, Regulation, Financial condition report, Communication, SLGG, Advertising, Social media, Analysis, Annual report, Security (finance), Super League, Letter, GAAP, Video game, Risk management

SANTA MONICA, Calif., Nov. 15, 2022 (GLOBE NEWSWIRE) -- Super League Gaming (Nasdaq: SLGG), a global leader in metaverse gaming and the young gamer creator economy, has announced preliminary, unaudited third quarter 2022 financial results in the form of a shareholder letter .The preliminary third quarter results are highlighted by continued revenue growth in-line with the Companys 2022 outlook, particularly in advertising and sponsorship revenue.

Key Points: 
  • SANTA MONICA, Calif., Nov. 15, 2022 (GLOBE NEWSWIRE) -- Super League Gaming (Nasdaq: SLGG), a global leader in metaverse gaming and the young gamer creator economy, has announced preliminary, unaudited third quarter 2022 financial results in the form of a shareholder letter .The preliminary third quarter results are highlighted by continued revenue growth in-line with the Companys 2022 outlook, particularly in advertising and sponsorship revenue.
  • Please visit the Super League Gaming investor relations website at https://ir.superleague.com/ to view CEO Ann Hands quarterly letter to shareholders.
  • For any questions regarding the Companys quarterly financial results, please contact [email protected] .
  • Super League Gaming (Nasdaq: SLGG) is a leading publisher of games, monetization tools and content channels across metaverse gaming platforms that empower developers, energize players, and entertain fans.

Reborn Coffee Reports Third Quarter 2022 Financial Results

Retrieved on: 
Tuesday, November 15, 2022
Marketing, COVID-19, Growth, Farm, Financial condition report, Conference, DTC, Mission Viejo, California, Analysis, Coffee, B2B, Laguna Woods, California, City, Risk, Form, Drink, Result, Risk management, IPO, Reborn

BREA, Calif., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Reborn Coffee, Inc. (NASDAQ: REBN) (Reborn, or the Company), a California-based retailer of specialty coffee, has reported its financial and operational results for the third quarter ended September 30, 2022.

Key Points: 
  • BREA, Calif., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Reborn Coffee, Inc. (NASDAQ: REBN) (Reborn, or the Company), a California-based retailer of specialty coffee, has reported its financial and operational results for the third quarter ended September 30, 2022.
  • In the third quarter of 2022 we continued to build the foundation for long-term growth with ongoing revenue execution and location expansion, said Jay Kim, Chief Executive Officer of Reborn.
  • Net loss for the third quarter of 2022 was approximately $0.9 million, compared to a net loss of approximately $1.9 million for the third quarter of 2021.
  • Reborn Coffee, Inc. (NASDAQ: REBN) is focused on serving high quality, specialty-roasted coffee at retail locations, kiosks, and cafes.

Arbe Announces First Mass Quantity Commercial Preliminary Order from HiRain Technologies

Retrieved on: 
Tuesday, November 15, 2022
Result, Radar, ADAS, Perception, Environment, Securities and Exchange Commission (Philippines), Conversation, Weather, TEL, Government, Analysis, Accident, Security (finance), OEM, SEC filing, Risk, Form, Financial condition report, Safety, Fine chemical, Instrumentation

TEL AVIV, Israel, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Arbe Robotics Ltd. (NASDAQ:ARBE) a global leader in Perception Radar Solutions, announced today thatHiRainTechnologies, the leading Chinese ADAS Tier 1 supplier, placed its first mass quantity commercial preliminary order for 2023 and 2024, moving Arbe into the mass production phase.

Key Points: 
  • TEL AVIV, Israel, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Arbe Robotics Ltd. (NASDAQ:ARBE) a global leader in Perception Radar Solutions, announced today thatHiRainTechnologies, the leading Chinese ADAS Tier 1 supplier, placed its first mass quantity commercial preliminary order for 2023 and 2024, moving Arbe into the mass production phase.
  • The order consists of 340,000 radar chipsets that will be supplied to HiRains customers throughout China.
  • Arbe has developed a strong relationship with the industry-leading tier 1, HiRain, and both companies are working together to supply the most advanced radar solution to customers throughout China, says Kobi Marenko, CEO of Arbe.
  • Arbe is a leader in the fast-growing automotive radar market that has a projected total addressable market of $11 billion in 2025.

Cue Biopharma Reports Third Quarter 2022 Financial Results

Retrieved on: 
Monday, November 14, 2022
COVID-19, Result, Financial condition report, Conversation, Food, Policy, Analysis, Food and Drug Administration, Annual report, Form 10-Q, Patent, PIPE, Cancer, Risk, Selective, Research, FDA

Cue Biopharma, a clinical-stage biopharmaceutical company, is developing a novel class of injectable biologics to selectively engage and modulate tumor-specific T cells directly within the patients body to transform the treatment of cancer.

Key Points: 
  • Cue Biopharma, a clinical-stage biopharmaceutical company, is developing a novel class of injectable biologics to selectively engage and modulate tumor-specific T cells directly within the patients body to transform the treatment of cancer.
  • The companys proprietary platform, Immuno-STAT (Selective Targeting and Alteration of T cells) and biologics are designed to harness the bodys intrinsic immune system as T cell engagers without the need for ex vivo manipulation.
  • Headquartered in Boston, Massachusetts, the company is led by an experienced management team and independent Board of Directors with deep expertise in immunology and immuno-oncology as well as the design and clinical development of protein biologics.
  • All statements other than statements of historical facts included in this press release regarding the companys strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements.

Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results

Retrieved on: 
Monday, November 14, 2022
Universe, Result, Sale, Blood, Trial of the century, Analysis, GlobalData, Ulcerative colitis, Syringe, Therapy, Patent, Patient, American College, DNA, Conference, Precision medicine, GI, Athyrium, Miniature pig, Research, Safety, Financial condition report, Disease, Parenteral Drug Association, Annual report, Adalimumab, Hand, Serri, Sardinia, American College of Gastroenterology, COVID-19, Colon, Comparison, SAN, Webcast, Roche Diagnostics, Medical device, Security (finance), Fine chemical, Pharmaceutical industry, Renewable energy, Motor vehicle, Reinsurance

Presented results of human study at the American College of Gastroenterology annual meeting, demonstrating promising device performance in active ulcerative colitis patients

Key Points: 
  • Presented results of human study at the American College of Gastroenterology annual meeting, demonstrating promising device performance in active ulcerative colitis patients
    SAN DIEGO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today provided a corporate update and reported financial results for the third quarter ended September30, 2022.
  • Biora also shared preclinical results from its systemic therapeutics program, demonstrating promising device performance using liquid jet injection to the small intestine in animal models.
  • Biora Therapeutics will host a webcast and conference call to discuss the third quarter financial results and answer investment community questions today, Monday, November 14, 2022 at 4:30 p.m. Eastern / 1:30 p.m. Pacific.
  • Biora Therapeutics expressly disclaims any obligation to update any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law.

Cue Biopharma Announces $30 Million Private Investment in Public Equity (PIPE) Financing

Retrieved on: 
Monday, November 14, 2022
FDA, PIPE, Result, Sale, Conversation, Analysis, Exercise, Patent, Warrant, Prospectus, Cancer, Life, Policy, Selective, Research, Financial condition report, Food and Drug Administration, Risk, Form 10-Q, Annual report, COVID-19, Food, Pharmaceutical industry, Security (finance)

The PIPE financing included a life sciences-focused investment fund that is a new investor in the company as well as participation from other new and existing investors.

Key Points: 
  • The PIPE financing included a life sciences-focused investment fund that is a new investor in the company as well as participation from other new and existing investors.
  • Piper Sandler & Co. acted as lead placement agent and Public Ventures LLC acted as co-placement agent to Cue Biopharma for the PIPE financing.
  • The exercise price of the Warrants is $3.93 per share, or if exercised for a Pre-Funded Warrant in lieu thereof, $3.9299 per Pre-Funded Warrant.
  • The Warrants are exercisable at any time after they are issued and ending on the fifth anniversary of the closing.